 |
 |

Evaluation of a New Antihypertensive AgentMinoxidil
Mary Ellen Kosman, PhD
JAMA. 1980;244(1):73-75.
Abstract
Minoxidil is a potent, long-acting, orally effective vasodilator that recently became available for general use in the United States. It is given with a diuretic and a β-blocking drug to treat severe hypertension that cannot be controlled by conventional therapy. Fluid retention and hypertrichosis are the most common adverse reactions.
(JAMA 244:73-75, 1980)
Author Affiliations
From the Department of Drugs, American Medical Association, Chicago.
Footnotes
This communication was prepared with the assistance of a panel of independent consultants.
Reprint requests to Department of Drugs, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (Dr Kosman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Effects of the Potassium Channel Opener Minoxidil on Renal Electrolytes Transport in the Loop of Henle
Wang
J. Pharmacol. Exp. Ther. 2003;304:833-840.
ABSTRACT
| FULL TEXT
Minoxidil-Induced Systemic Lupus Erythematosus
Tunkel et al.
Arch Intern Med 1987;147:599-600.
ABSTRACT
Review of the Overall Experience of Captopril in Hypertension
Frohlich et al.
Arch Intern Med 1984;144:1441-1444.
ABSTRACT
|